Tenaya Therapeutics, Inc. (TNYA)
0.8404
+0.05
(+6.35%)
USD |
NASDAQ |
May 07, 16:00
0.8255
-0.01
(-1.77%)
After-Hours: 20:00
Tenaya Therapeutics Cash from Investing (Quarterly) : -0.067M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Vericel Corp. | -16.39M |
| Anavex Life Sciences Corp. | 0.00 |
| Protagonist Therapeutics, Inc. | 90.89M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.94M |
| Cash from Financing (Quarterly) | 58.24M |
| Free Cash Flow | -68.88M |
| Free Cash Flow Per Share (Quarterly) | -0.08 |
| Free Cash Flow to Equity (Quarterly) | -13.31M |
| Free Cash Flow to Firm (Quarterly) | -14.01M |
| Free Cash Flow Yield | -53.65% |